fMLP is a peptide chemoattractant released by certain bacteria and mitochondria at a site of tissue infection and/or injury, and activates neutrophils by interacting with the formyl peptide receptor on the neutrophil surface (Fig. 7) (43). This evidence concerns the gene FPR1 and infection.